Seminarid

Soovitatavad seminarid

AKTIIVNE

Updates on ESC heart failure guidelines

TULEMAS

Dapagliflozin: Cardiologist Practical Guide to Prescribing Dapagliflozin

AKTIIVNE

Practicalities of SGLT2 inhibition – pros vs cons

TULEMAS

Can new-onset diabetes be prevented by dapagliflozin? Insights from DAPA-HF

TULEMAS

Can new-onset diabetes be prevented by dapagliflozin? Insights from DAPA-HF

AKTIIVNE

Practicalities of SGLT2 inhibition – pros vs cons

TULEMAS

Dapagliflozin: Cardiologist Practical Guide to Prescribing Dapagliflozin

AKTIIVNE

COVID-19 and its implications in heart failure